Monashee Investment Management LLC Sage Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$81.94 - $139.71 $1.64 Million - $2.79 Million	-20,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $2.21 Million - $2.7 Million	-16,000 Reduced 44.44%	20,000 $2.83 Million
Q2 2018 Aug 10, 2018	SELL	$140.36 - $175.76 $10.4 Million - $13 Million	-74,000 Reduced 67.27%	36,000 $5.64 Million
Q1 2018 May 10, 2018	BUY	$152.15 - $192.33 $9.13 Million - $11.5 Million	60,000 Added 120.0%	110,000 $17.7 Million
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $3.04 Million - $8.37 Million	50,000	50,000 $8.24 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.